Are you between 18 and 65 years old and being treated for depression? Even if your symptoms have improved, you may still be at risk for them coming back. You may be able to take part in a research study exploring a potential new treatment option.
Depression Study
Age Range:
18 to 65
Gender:
Male and Female
Location:
Media, Pennsylvania
About the Study
This research study is looking at an investigational medication called brenipatide, which is being studied alongside your current antidepressant treatment. The goal is to learn whether it may help delay or prevent the return of depression symptoms.
Participants will continue taking their current prescribed antidepressant and will receive either the study medication or a placebo (a treatment with no active medication). Study doctors will closely monitor your health, symptoms, and overall well-being throughout the study.
Qualifications
You may be able to join if you:
- Are 18 to 65 years old
- Have been diagnosed with depression (Major Depressive Disorder)
- Are currently feeling better, but still have some remaining symptoms
- Have experienced depression more than once in your life
- Are taking an antidepressant and are willing to stay on your current treatment during the study
FEATURED STUDIES
MDD Study
Adults 18 to 65 years of age with Major Depressive Disorder (MDD) may qualify for a clinical research study evaluating
Asthma
Adults and adolescents 12 years of age and older living with asthma may qualify for a clinical research study evaluating
Chronic Obstructive Pulmonary Disease (COPD)
Adults 40–75 who have COPD and experienced a flare-up in the past year may qualify for a study evaluating an
Post-Traumatic Stress Disorder (PTSD)
Adults 18 and older living with post-traumatic stress disorder (PTSD) may qualify for a clinical research study evaluating an investigational
Bronchiectasis
Individuals with bronchiectasis who experience frequent flare-ups or ongoing respiratory symptoms may qualify for a research study evaluating a home
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for